Famotidine (Pepcid) is Safe for Patients with Glaucoma Experiencing Allergic Reactions
Yes, famotidine is safe to use in patients with glaucoma who are experiencing an allergic reaction, as there are no contraindications between famotidine and glaucoma, and the drug does not affect intraocular pressure.
Safety Profile in Glaucoma
The FDA label for famotidine lists only hypersensitivity to H2-receptor antagonists as a contraindication—glaucoma is not mentioned 1. This is supported by a large cohort study of 71,108 patients using H2-antagonists (including famotidine) over 101,827 person-years, which found an incidence rate ratio of 0 for serious ocular disorders compared to non-users (95% CI: 0-2.1), confirming the ocular safety of these medications 2.
The comprehensive glaucoma guidelines from the European Glaucoma Society and American Academy of Ophthalmology focus exclusively on IOP-lowering medications (prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, etc.) and make no mention of avoiding H2-antagonists or famotidine in glaucoma patients 3. This absence of any warning or precaution in authoritative glaucoma guidelines further supports safety.
Important Caveat: Famotidine Can Cause Allergic Reactions
However, you must be aware that famotidine itself can paradoxically cause allergic reactions, including anaphylaxis, though this is rare.
- IgE-mediated anaphylaxis to famotidine has been documented with positive skin testing, including cross-reactivity with other H2-antagonists (ranitidine, nizatidine) 4
- Hypersensitivity reactions include maculopapular rash with eosinophilia 5 and anaphylaxis requiring epinephrine 6
- The overall safety profile remains excellent with 18.8 million patients treated worldwide showing minimal adverse events 7
Clinical Algorithm
If treating an allergic reaction in a glaucoma patient:
- Famotidine is safe from a glaucoma perspective - no IOP effects or contraindications
- Verify the patient has no prior H2-antagonist allergy - check for previous reactions to famotidine, ranitidine, cimetidine, or nizatidine 1
- If the patient is currently having an allergic reaction to an unknown trigger, consider that famotidine itself could theoretically be a culprit if recently started, though this is uncommon
- Monitor for hypersensitivity - watch for rash, dyspnea, or anaphylaxis during administration, particularly with IV formulation 4, 6
The glaucoma medications themselves (prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors) should be continued without interruption 3, as maintaining target IOP is critical to prevent vision loss and preserve quality of life.